The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers
Open accessAbstract
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) antibody measurements can be used to estimate the proportion of a population exposed or infected and may be informative about the risk of future infection. Previous estimates of the duration of antibody responses vary. Methods: We present 6 months of data from a longitudinal seroprevalence study of 3276 UK healthcare workers (HCWs). Serial measurements of SARS-CoV-2 anti-nucleocapsid and anti-spike IgG were obtained. Interval censored survival analysis was used to investigate the duration of detectable responses. Additionally, Bayesian mixed linear models were used to investigate anti-nucleocapsid waning. Results: Anti-spike IgG levels remained stably detected after a positive result, for example, in 94% (95% credibility interval [CrI] 91–96%) of HCWs at 180 days. Anti-nucleocapsid IgG levels rose to a peak at 24 (95% CrI 19–31) days post first polymerase chain reaction (PCR)-positive test, before beginning to fall. Considering 452 anti-nucleocapsid seropositive HCWs over a median of 121 days from their maximum positive IgG titer, the mean estimated antibody half-life was 85 (95% CrI 81–90) days. Higher maximum observed anti-nucleocapsid titers were associated with longer estimated antibody half-lives. Increasing age, Asian ethnicity, and prior self-reported symptoms were independently associated with higher maximum anti-nucleocapsid levels and increasing age and a positive PCR test undertaken for symptoms with longer anti-nucleocapsid half-lives. Conclusions: SARS-CoV-2 anti-nucleocapsid antibodies wane within months and fall faster in younger adults and those without symptoms. However, anti-spike IgG remains stably detected. Ongoing longitudinal studies are required to track the long-term duration of antibody levels and their association with immunity to SARS-CoV-2 reinfection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
To, K. K.-W., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C.-Y., Cai, J.-P., Chan, J. M.-C., Chik, T. S.-H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,066
Antibody responses to SARS-CoV-2 in patients with COVID-19
Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853
Seow, J., Graham, C., Merrick, B., Acors, S., Pickering, S., Steel, K. J. A., Hemmings, O., O’Byrne, A., Kouphou, N., Galao, R. P., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00813-8 · Cited by 1,419
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Wajnberg, A., Amanat, F., Firpo, A., Altman, D. R., Bailey, M. J., Mansour, M., McMahon, M., Meade, P., Mendu, D. R., Muellers, K., et al. (2020) · Science · doi:10.1126/science.abd7728 · Cited by 1,195
Huang, A. T., Garcia-Carreras, B., Hitchings, M. D. T., Yang, B., Katzelnick, L. C., Rattigan, S. M., Borgert, B. A., Moreno, C. A., Solomon, B. D., Trimmer-Smith, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18450-4 · Cited by 1,026
Humoral Immune Response to SARS-CoV-2 in Iceland
Gudbjartsson, D. F., Norddahl, G. L., Melsted, P., Gunnarsdottir, K., Holm, H., Eythorsson, E., Arnthorsson, A. O., Helgason, D., Bjarnadottir, K., Ingvarsson, R. F., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2026116 · Cited by 903
Antibody tests for identification of current and past infection with SARS‐CoV‐2
Geppert, J., Scandrett, K., Bigio, J., Sulis, G., Hettiarachchi, D., Mathangasinghe, Y., Weeratunga, P., Wickramasinghe, D., Bergman, H., Buckley, S. B., et al. (2022) · LSTM Online Archive (Liverpool School of Tropical Medicine) · Cited by 842
Seasonal coronavirus protective immunity is short-lasting
Edridge, A. W. D., Kaczorowska, J., Hoste, A. C. R., Bakker, M., Klein, M., Loens, K., Jebbink, M. F., Matser, A., Kinsella, C. M., Rueda, P., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1083-1 · Cited by 767
Cited by
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
Lumley, S. F., O’Donnell, D., Stoesser, N. E., Matthews, P. C., Howarth, A., Hatch, S. B., Marsden, B. D., Cox, S., James, T., Warren, F., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034545 · Cited by 940
Self-citationFiolet, T., Kherabi, Y., MacDonald, C.-J., Ghosn, J., & Peiffer-Smadja, N. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.10.005 · Cited by 911
Buss, L. F., Prete, C. A., Abrahim, C. M. M., Mendrone, A., Salomon, T., de Almeida-Neto, C., França, R. F. O., Belotti, M. C., Carvalho, M. P. S. S., Costa, A. G., et al. (2021) · Science · doi:10.1126/science.abe9728 · Cited by 488
Ely, E. W., Brown, L. M., & Fineberg, H. V. (2024) · New England Journal of Medicine · doi:10.1056/nejmsb2408466 · Cited by 340
Abu Jabal, K., Ben-Amram, H., Beiruti, K., Batheesh, Y., Sussan, C., Zarka, S., & Edelstein, M. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.6.2100096 · Cited by 271
Metadata
- Authors
- Lumley, S. F., Wei, J., O’Donnell, D., Stoesser, N. E., Matthews, P. C., Howarth, A., Hatch, S. B., Marsden, B. D., Cox, S., James, T., Peck, L. J., Ritter, T. G., de Toledo, Z., Cornall, R. J., Jones, E. Y., Stuart, D. I., Screaton, G., Ebner, D., Hoosdally, S., Crook, D. W., Conlon, C. P., Pouwels, K. B., Walker, A. S., Peto, T. E. A., Walker, T. M., Jeffery, K., Eyre, D. W., Oxford University Hospitals Staff Testing Group, Abbott, M., Abhari, R., Abuelgasim, H., Ahmed-Firani, T., Alhussni, A., Argles, I., Ashworth, R., Back, F., Black, S., Brennan, I., Cansdale, L., Chakravorty, T., Choudhury, Z., Clay, H., Conway-Jones, R., Curtis, A., Cutteridge, J., Danbury, H., Davies, H., Denly, L., Dequaire, J., Dimitrov, S., Dunlop, E., Dunn, P., East, C., Eastwood, B., Edwardes, C., Evans, M., Fields, C., Flaherty, S., Foord, T., Freer, R., Fuchs, H., Grassam-Rowe, A., Greenan-Barrett, L., Gunnell, J., Harries, C., Harris, E., Hatton, E., Hennessy, C., Holland, C., Holloway, B., Howgego, G., Barnham, I. J., Johnson, S., Johnson, T., Johnstone, D., Jurdon, R., Kelly, G., Kerneis, S., Khulusi, B., Killen, A., Kourdov, S., Kumarendran, M., Laurenson-Schafer, H., Lawrence, R., Lee, C., Livingstone, A., Lynch, R., Madsen, T., Manji, A., Marsh, J., Mason, C., Mccance, A., Mcgivern, E., Mckinlay, A., Mighiu, A., Millar, L., Mohamed, Y., Motohashi, K., Myat, S., Nezhentsev, A., O’Byrne, K., Okuwoga, T., Oliver, M., Pattenden, S., Perera, V., Petit, Y., Pickles, F., Pikoula, M., Randhawa, G., Ravi, K., Reed, L., Rigler, C., Robinson, C., Rothwell, E., Santos-Paulo, S., Savva, C., Scharmeli, A., Scott, S., Shabir, Z., Sharma, I., Sheehan, R., Shibu, A., Somanathan, A., Sussmes, S., Sweeney, O., Swift, E., Tadikamalla, G., Tamblyn, M., Taylor, A., Naudé, R. T. W., Thomas, S., Thompson, C., Till, L., Toward, R., Virgo, C., Vorley, I., Waite, S., Ward, H., Ward, J., Watson, A., Watson, L., Wedlich, M., Wilkins, L., Wilson, J., Wilson, J., Wong, W., Young, R., Doherty, G., Kavanagh, J., Chau, K. K., Fowler, P. W., Swann, J., Volk, D., Yang-Turner, F., Skelly, D., Karpe, F., Neville, M. J., Ferreira, L. M., Christott, T., Rodger, G., Pickford, H., Cameron, S., Tamblin-Hopper, P., Amini, A., Andersson, M., Anson, K., Aston, L., Axten, D., Barot, S., Bellinger, T., Bialek, A., Bodo, N., Brent, A., Campbell, M., Cox, V., Cronin, T., Davies, T., Deales, A., Downs, L., Drennan, P., Dudareva, M., Gates, L., Gates, M., Georgiou, D., Gergely, B., Holland, L., Jones, N., Jones, S., Kerr, S., Lawson, E., Looms, S., Luciw, M., Martins, D., Mcknight, M., Mentzer, A., Millard, R., Mitchell, T., Morgan, L., Morrow, J., Mortimore, E., Mullins, H., Nevard, H., O’Donnell, A.-M., Patel, K., Peto, L., Philips, J., Ponting, J., Ray, R., Robles, M., Rughani, S., Sande, N., Shaw, R., Simons, E.-J., Sims, E., Smit, K., Smith, L., Szczurkowska, J., Thompson, Z., Turford, R., Vilca, K., Vogt, A., Warren, F., Warren, L., Wharton, V., Whitty, A., Woodley, H., Wozniak, B., Young, B., Justice, A., Jesuthasan, G., Wareing, S., Fadzillah, N. H. M., Cann, K., Kirton, R., Sutton, C., Salvagno, C., D’Amato, G., Pill, G., Butcher, L., Rylance-Knight, L., Tabirao, M., Moroney, R., & Wright, S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-01-06
- Volume
- 73
- Issue
- 3
- Pages
- e699-e709
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W3096525230
- Cited by
- 288
- References
- 26
- FWCI
- 19.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers. https://app.cochat.ai/papers/10.1093/cid/ciab004
- The paper
- Lumley, S. F., Wei, J., O’Donnell, D., Stoesser, N. E., Matthews, P. C., Howarth, A., Hatch, S. B., Marsden, B. D., Cox, S., James, T., Peck, L. J., Ritter, T. G., de Toledo, Z., Cornall, R. J., Jones, E. Y., Stuart, D. I., Screaton, G., Ebner, D., Hoosdally, S., . . . Wright, S. (2021). The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciab004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.